The conference provides an opportunity for all stakeholders in the field to network and explore potential collaborations. Global biotechnology and pharmaceutical companies, patient groups and foundations, government agencies, investors, and regulatory folks will discuss partnering strategies as well as emerging research areas and trends to watch. This meeting seeks to form discussion on all topics from bench to bedside, from changing paradigms in scientific approaches in CNS disorders to partnerships for open innovation to pricing and reimbursement considerations.